Search

Methods for the elimination of police corruption to enhance integrity, usually disregards its roots that are connected to societal elements in light of the fact that police corruption has societal causes and implementing a change of the police needs, to certain degree, transforming the community. In this research, a qualitative approach (semi-structured interviews, focus group meetings and observations) was used the analysis methods from social profiles categorized as per their degree of police corruption utilizing data. Researchers have described and examined the organizational and social determinants of police corruption to help decision-makers establish social and economic policy frameworks to monitor police corruption. Researchers concluded that poor pay, resource shortage, moral economy, and politicization of police are pertinent to police corruption. In addition, research evidence suggests that the government must increasingly strengthen organizational as well as social measures in order to minimize police corruption.

Abstract Analyzing the microscopic dynamics of pushing behavior within crowds can offer valuable insights into crowd patterns and interactions. By identifying instances of pushing in crowd videos, a deeper understanding of when, where, and why such behavior occurs can be achieved. This knowledge is crucial to creating more effective crowd management strategies, optimizing crowd flow, and enhancing overall crowd experiences. However, manually identifying pushing behavior at the microscopic level is challenging, and the existing automatic approaches cannot detect such microscopic behavior. Thus, this article introduces a novel automatic framework for identifying pushing in videos of crowds on a microscopic level. The framework comprises two main components: (i) feature extraction and (ii) video detection. In the feature extraction component, a new Voronoi-based method is developed for determining the local regions associated with each person in the input video. Subsequently, these regions are fed into EfficientNetV1B0 Convolutional Neural Network to extract the deep features of each person over time. In the second component, a combination of a fully connected layer with a Sigmoid activation function is employed to analyze these deep features and annotate the individuals involved in pushing within the video. The framework is trained and evaluated on a new dataset created using six real-world experiments, including their corresponding ground truths. The experimental findings demonstrate that the proposed framework outperforms state-of-the-art approaches, as well as seven baseline methods used for comparative analysis.

ObjectiveTo assess our hypothesis that brain macrostructure is different in individuals with mucopolysaccharidosis type I (MPS I) and healthy controls (HC), we conducted a comprehensive multicenter study using a uniform quantitative magnetic resonance imaging (qMRI) protocol, with analyses that account for the effects of disease phenotype, age, and cognition.MethodsBrain MRIs in 23 individuals with attenuated (MPS IA) and 38 with severe MPS I (MPS IH), aged 4-25 years, enrolled under the study protocol NCT01870375, were compared to 98 healthy controls.ResultsCortical and subcortical gray matter, white matter, corpus callosum, ventricular and choroid plexus volumes in MPS I significantly differed from HC. Thicker cortex, lower white matter and corpus callosum volumes were already present at the youngest MPS I participants aged 4-5 years. Age-related differences were observed in both MPS I groups, but most markedly in MPS IH, particularly in cortical gray matter metrics. IQ scores were inversely associated with ventricular volume in both MPS I groups and were positively associated with cortical thickness only in MPS IA.ConclusionsQuantitatively-derived MRI measures distinguished MPS I participants from HC as well as severe from attenuated forms. Age-related neurodevelopmental trajectories in both MPS I forms differed from HC. The extent to which brain structure is altered by disease, potentially spared by treatment, and how it relates to neurocognitive dysfunction needs further exploration.

Background Vitiligo is an autoimmune skin disorder characterized by depigmented patches of skin, which can have significant psychological impacts. Objectives To estimate the lifetime incidence of vitiligo, overall, by ethnicity and across other sociodemographic subgroups, and to investigate the impacts of vitiligo on mental health, work and healthcare utilization. Methods Incident cases of vitiligo were identified in the Optimum Patient Care Database of primary care records in the UK between 1 January 2004 and 31 December 2020. The lifetime incidence of vitiligo was estimated at age 80 years using modified time-to-event models with age as the timescale, overall and stratified by ethnicity, sex and deprivation. Depression, anxiety, sleep disturbance, healthcare utilization and work-related outcomes were assessed in the 2 years after vitiligo diagnosis and compared with matched controls without vitiligo. The study protocol for this retrospective observational study was registered with ClinicalTrials.gov (NCT06097494). Results In total, 9460 adults and children were newly diagnosed with vitiligo during the study period. The overall cumulative lifetime incidence was 0.92% at 80 years of age [95% confidence interval (CI) 0.90–0.94]. Cumulative incidence was similar in female (0.94%, 95% CI 0.92–0.97) and male patients (0.89%, 95% CI 0.86–0.92). There were substantial differences in lifetime incidence across ethnic groups, listed by Office for National Statistics criteria [Asian 3.58% (95% CI 3.38–3.78); Black 2.18% (95% CI 1.85–2.50); Mixed/multiple 2.03% (95% CI 1.58–2.47); Other 1.05% (95% CI 0.94–1.17); and White 0.73% (95% CI 0.71–0.76)]. Compared with matched controls, people with vitiligo had an increased risk of depression [adjusted odds ratio (aOR) 1.08, 95% CI 1.01–1.15]; anxiety (aOR 1.19, 95% CI 1.09–1.30); depression or anxiety (aOR 1.10, 95% CI 1.03–1.17); and sleep disturbance [adjusted hazard ratio (aHR) 1.15, 95% CI 1.02–1.31]. People with vitiligo also had a greater number of primary care encounters (adjusted incidence rate ratio 1.29, 95% CI 1.26–1.32) and a greater risk of time off work (aHR 1.15, 95% CI 1.06–1.24). There was little evidence of disparities in vitiligo-related impacts across ethnic subgroups. Conclusions Clinicians should be aware of the markedly increased incidence of vitiligo in people belonging to Asian, Black, Mixed/multiple and Other groups. The negative impact of vitiligo on mental health, work and healthcare utilization highlights the importance of monitoring people with vitiligo to identify those who need additional support. [ABSTRACT FROM AUTHOR]

Copyright of Egyptian Journal of Haematology is the property of Wolters Kluwer India Pvt Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The article discusses the concept of 'psycholag,' which refers to the delay between physical and psychological improvement in patients with skin diseases undergoing systemic therapies. It explores how the clearance of skin disease may not always lead to immediate psychological improvement, with psychological symptoms sometimes lagging behind physical changes. The text also delves into the potential link between systemic inflammation, cytokine dysregulation, and psychiatric symptoms, suggesting that treating systemic inflammation may impact psychosocial symptoms. The authors emphasize the importance of considering psychological and emotional parameters alongside physical outcomes when evaluating treatment success for patients with skin diseases. [Extracted from the article]

ObjectivesPrecise characterization of cognitive outcomes and factors that contribute to cognitive variability will enable better understanding of disease progression and treatment effects in mucopolysaccharidosis type I (MPS I). We examined the effects on cognition of phenotype, genotype, age at evaluation and first treatment, and somatic disease burden.MethodsSixty patients with severe MPS IH (Hurler syndrome treated with hematopoietic cell transplant and 29 with attenuated MPS I treated with enzyme replacement therapy), were studied with IQ measures, medical history, genotypes. Sixty-seven patients had volumetric MRI. Subjects were grouped by age and phenotype and MRI and compared to 96 normal controls.ResultsPrior to hematopoietic cell transplant, MPS IH patients were all cognitively average, but post-transplant, 59% were below average, but stable. Genotype and age at HCT were associated with cognitive ability. In attenuated MPS I, 40% were below average with genotype and somatic disease burden predicting their cognitive ability. White matter volumes were associated with IQ for controls, but not for MPS I. Gray matter volumes were positively associated with IQ in controls and attenuated MPS I patients, but negatively associated in MPS IH.ConclusionsCognitive impairment, a major difficulty for many MPS I patients, is associated with genotype, age at treatment and somatic disease burden. IQ association with white matter differed from controls. Many attenuated MPS patients have significant physical and/or cognitive problems and receive insufficient support services. Results provide direction for future clinical trials and better disease management.

UnlabelledThe phenotype of attenuated mucopolysaccharidosis type II (MPS II), also called Hunter syndrome, has not been previously studied in systematic manner. In contrast to the "severe" phenotype, the "attenuated" phenotype does not present with behavioral or cognitive impairment; however, the presence of mild behavior and cognitive impairment that might impact long-term functional outcomes is unknown. Previously, significant MRI abnormalities have been found in MPS II. Recent evidence suggests white matter abnormalities in many MPS disorders.MethodsAs the initial cross-sectional analysis of a longitudinal study, we studied the association of brain volumes and somatic disease burden with neuropsychological outcomes, including measures of intelligence, memory, and attention in 20 patients with attenuated MPS II with a mean age of 15.8. MRI volumes were compared to 55 normal controls.ResultsWhile IQ and memory were average, measures of attention were one standard deviation below the average range. Corpus callosum volumes were significantly different from age-matched controls, differing by 22%. Normal age-related volume increases in white matter were not seen in MPS II patients as they were in controls. Somatic disease burden and white matter and corpus callosum volumes were significantly associated with attention deficits. Neither age at evaluation nor age at starting treatment predicted attention outcomes.ConclusionsDespite average intelligence, attention is compromised in attenuated MPS II. Results confirm an important role of corpus callosum and cortical white matter abnormality in MPS II as well as the somatic disease burden in contributing to attention difficulties. Awareness by the patient and caregivers with appropriate management and symptomatic support will benefit the attenuated MPS II patient.

A comprehensive understanding of the root structure is important for the successful outcome of endodontic procedures. Lack of knowledge of the anatomic variations in root canal morphology can contribute to the failure of root canal therapy. One of the most anatomically diverse tooth groups is the upper first premolar. The incidence of two root canals is the most predominant anatomy observed for maxillary first premolar however some anatomical variations are also observed. The most frequent anatomical variation in these teeth is the existence of three roots with three canals. The objective of this study is to report a similar case of maxillary first premolar having three roots with separate 3 canals. Endodontic success requires a thorough understanding of root canal anatomy. The variation in the number of roots, canals, root direction, longitudinal depressions of the roots, the various shapes of the pulp cavity and the problems in visualizing the apical limit by radiographs make the endodontic procedure of these teeth quite challenging. [ABSTRACT FROM AUTHOR]

Cerebellar atrophy is a characteristic sign of late‐onset Tay‐Sachs disease (LOTS). Other structural neuroimaging abnormalities are inconsistently reported. Our study aimed to perform a detailed whole‐brain analysis and quantitatively characterize morphometric changes in LOTS patients. Fourteen patients (8 M/6F) with LOTS from three centers were included in this retrospective study. For morphometric brain analyses, we used deformation‐based morphometry, voxel‐based morphometry, surface‐based morphometry, and spatially unbiased cerebellar atlas template. The quantitative whole‐brain morphometric analysis confirmed the finding of profound pontocerebellar atrophy with most affected cerebellar lobules V and VI in LOTS patients. Additionally, the atrophy of structures mainly involved in motor control, including bilateral ventral and lateral thalamic nuclei, primary motor and sensory cortex, supplementary motor area, and white matter regions containing corticospinal tract, was present. The atrophy of the right amygdala, hippocampus, and regions of occipital, parietal and temporal white matter was also observed in LOTS patients in contrast with controls (p < 0.05, FWE corrected). Patients with dysarthria and those initially presenting with ataxia had more severe cerebellar atrophy. Our results show predominant impairment of cerebellar regions responsible for speech and hand motor function in LOTS patients. Widespread morphological changes of motor cortical and subcortical regions and tracts in white matter indicate abnormalities in central motor circuits likely coresponsible for impaired speech and motor function. [ABSTRACT FROM AUTHOR]